EAGLE PHARMACEUTICALS INC shareholders Q3 2023

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MetLife Investment Management, LLC 5,468$86,2300.00%
China Universal Asset Management Co., Ltd. 334$50.00%
AMERICAN CENTURY COMPANIES INC 98,365$1,551,2160.00%
Citadel Advisors 1,400$22,0780.00%
Tower Research Capital LLC (TRC) 945$14,9020.00%
CWM, LLC 1,064$170.00%
JPMORGAN CHASE & CO 63,144$995,7810.00%
Nordwand Advisors, LLC 100$1,5770.00%
BARCLAYS PLC 10,622$1680.00%
ROYAL BANK OF CANADA 1,862$29,0000.00%
Gradient Investments LLC 29$4570.00%
VANGUARD GROUP INC 643,597$10,149,5240.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2,283$36,0030.00%
UBS Group AG 17,872$281,8420.00%
ALLIANCEBERNSTEIN L.P. 21,390$337,3200.00%
RHUMBLINE ADVISERS 17,132$270,1610.00%
Glassman Wealth Services 59$9300.00%
Squarepoint Ops LLC 10,885$171,6560.00%
BNP PARIBAS FINANCIAL MARKETS 18,527$292,1710.00%
OSAIC HOLDINGS, INC. 1,370$21,6020.00%
External links

This page lists EAGLE PHARMACEUTICALS INC's shareholders in Q3 2023. To view EAGLE PHARMACEUTICALS INC's shareholder history, click here.